German observational multicenter study of patients with Fabry disease under enzyme replacement therapy with pegunigalsidase-alfa

Beteiligte Wissenschaftlerin:
Dr. rer. medic. Dipl.-Stat. Maria Eveslage

Studienleitung:
Prof. Dr. Dr. med. Eva Brand

The GoPEG study is a single-arm observational multicenter study in patients with Fabry disease. The objective of the study is to document long-term data on treatment with pegunigalsidase-alfa under “real world” conditions.